Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis

Osteoblasts express two key molecules for osteoclast differentiation, receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG), a soluble decoy receptor for RANKL. RANKL induces osteoclastogenesis, while OPG inhibits it by blocking the binding of RANKL to RANK, a cellular receptor of RAN...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:PLoS One
मुख्य लेखकों: Ozaki, Yuki, Koide, Masanori, Furuya, Yuriko, Ninomiya, Tadashi, Yasuda, Hisataka, Nakamura, Midori, Kobayashi, Yasuhiro, Takahashi, Naoyuki, Yoshinari, Nobuo, Udagawa, Nobuyuki
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Public Library of Science 2017
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5609750/
https://ncbi.nlm.nih.gov/pubmed/28937990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0184904
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन